Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/530317 stock hub

BOM/530317 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/530317is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

980.1M

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/530317

In the news

Latest news · BOM/530317

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E26.5

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC5.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/530317 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

INR

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	106
Employees Change	-5%
Employees Change Percent	-4.5
Enterprise value	INR 1.7B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 980.1M
Price	INR 130
Price currency	INR
Rev Per Employee	9,310,792.45x
Sic	2834
Symbol	bom/530317
Website	https://godavaridrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.77%
EV Earnings	45.96x
EV/EBIT	19.17x
EV/EBITDA	15.02x
EV/Sales	1.72x
P/B ratio	2.16x
P/E ratio	26.51x
P/S ratio	0.99x
PE Ratio10 Y	15.17x
PE Ratio3 Y	15.72x
PE Ratio5 Y	13.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.97%
EBITDA Margin	11.45%
Gross margin	28.13%
Gross Profit	INR 277.6M
Gross Profit Growth	-17.75%
Gross Profit Growth Q	11.51%
Gross Profit Growth3 Y	-0.89%
Gross Profit Growth5 Y	3.94%
Net Income	INR 36.9M
Net Income Growth	-39.96%
Net Income Growth Q	-1.28%
Net Income Growth3 Y	-0.27%
Net Income Growth5 Y	0.52%
Pretax Margin	4.95%
Profit Margin	3.74%
Profit Per Employee	INR 348,255
Roa5y	5.77
Roe5y	15.18
ROIC	5.71
Roic5y	11.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.92%
Cagr15y	19.72%
Cagr1y	40.14%
Cagr20y	10.12%
Cagr3y	17.66%
Cagr5y	15.58%
EPS Growth	-39.93
EPS Growth Q	-0.98
EPS Growth3 Y	-0.26
EPS Growth5 Y	0.51
Revenue Growth	-22.2x
Revenue Growth Q	-25.12x
Revenue Growth3 Y	-16.09x
Revenue Growth5 Y	-2.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 22.9M
Debt	INR 739.3M
Debt EBITDA	INR 6.54
Debt Equity	INR 1.63
Equity	INR 453.9M
Interest Coverage	2.14
Net Cash	INR -716.4M
Net Cash By Market Cap	INR -73.09
Net Debt EBITDA	INR 6.34
Net Debt Equity	INR 1.58
Tangible Book Value	INR 453.9M
Tangible Book Value Per Share	INR 60.32
WACC	5.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	208.31%
1Y total return	40.11%
200-day SMA	87.12
3Y total return	62.92%
50-day SMA	97.26
50-day SMA vs 200-day SMA	50over200
5Y total return	106.21%
All Time High	155
All Time High Change	-18.65%
All Time High Date	2024-08-30
All Time Low	1.75
All Time Low Change	7,105.71%
All Time Low Date	2002-01-25
ATR	7.43
Beta	0.36
Beta1y	0.5
Beta2y	0.43
Ch YTD	64.13
High	131.5
High52	133
High52 Date	2026-04-29
High52ch	-2.11%
Low	124.2
Low52	69.7
Low52 Date	2025-12-09
Low52ch	86.73%
Ma50ch	29.65%
Price vs 200-day SMA	44.75%
RSI	70.33
RSI Monthly	64.63
RSI Weekly	69.32
Sharpe ratio	0.89x
Sortino ratio	1.75
Total Return	0.06%
Tr YTD	64.13
Tr15y	1,387.03%
Tr1m	38.57%
Tr1w	0.24%
Tr3m	35.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 88.5M
Operating Income Growth	-22.4
Operating Income Growth Q	-7.36
Operating Income Growth3 Y	1.09
Operating Income Growth5 Y	2.91
Operating margin	8.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,722,931%
Shares Insiders	59.86%
Shares Out	7,530,500
Shares Qo Q	-0.31%
Shares Yo Y	-0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	20,109.35x
Bv Per Share	60.32
Ch10y	208.3
Ch15y	1,387
Ch1m	38.57
Ch1w	0.24
Ch1y	40.11
Ch20y	587.2
Ch3m	35.36
Ch3y	62.92
Ch5y	106.2
Ch6m	53.82
Change	3.21%
Change From Open	1.68
Close	126.1
Days Gap	1.51
Depreciation Amortization	24,476,000
Dollar Volume	2,572,675.1
Earnings Date	2026-05-30
EBIT	INR 88.5M
EBITDA	INR 113M
EPS	INR 4.91
F Score	2
Fiscal Year End	March
Founded	1,987
Graham Number	81.62866
Graham Upside	-35.27
Income Tax	INR 11.9M
Is Primary Listing	1
Last Earnings Date	2026-02-14
Last Report Date	2025-12-31
Lynch Fair Value	INR 24.55
Lynch Upside	-80.53
Ma150	87.89
Ma150ch	43.48%
Ma20	117.3
Ma20ch	7.48%
Next Earnings Date	2026-05-30
Open	128
Position In Range	82.07
Price Date	2026-05-08
Price EBITDA	INR 8.68
Ptbv Ratio	2.16
Relative Volume	0.98x
Revenue	986,944,000x
Tax By Revenue	1.21x
Tax Rate	24.44%
Tr20y	587.19%
Tr6m	53.82%
Volume	19,767

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/530317 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/530317 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/530317?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+59.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

BOM/530317 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.3

Above 70: short-term overbought

Price vs 200-day MA

+44.7%

50/200-day relationship not available

Beta (5Y)

0.36

Less volatile than the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/530317

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/530317 stock rating?

bom/530317 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/530317 analysis?

The full report lives at /stocks/bom/530317/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/530317?

The latest report frames bom/530317 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/530317 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.